Mesoblast is in active discussions with US and other government authorities as well as potential pharmaceutical partners with respect to its plans for ramp-up of commercial manufacturing for remestemcel-L in COVID-19 ARDS.2
Ann: Appendix 4C - quarterly
-
- There are more pages in this discussion • 203 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.5¢ |
Change
-0.015(1.53%) |
Mkt cap ! $1.116B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 96.0¢ | $3.549M | 3.639M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 247905 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 168962 | 21 |
View Market Depth
| Last trade - 14.28pm 26/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |